Complement pathway dysregulation in schizophrenia; from biomarkers to potential target for novel therapies

The session will explain the recent findings showing that the complement pathway is altered in psychosis with implications for new treatment, treatment stratification, and prevention.

Chair: Professor David Cotter, Royal College of Surgeons in Ireland

Complement pathway dysregulation in schizophrenia; prediction of transition from the clinical high risk to psychotic disorder - David Mongan, Queens University Belfast

Response to treatment in first episode psychosis linked to levels of complement and coagulation proteins - Dr Subash Raj Susai, Royal College of Surgeons in Ireland

Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis - Dr Meike Heurich, Cardiff University